As of 2025-07-09, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is -40.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 322.07 mil USD. HCAT's TTM EBITDA according to its financial statements is -7.93 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.7x | 11.8x |
| Forward P/E multiples | 11.9x - 19.4x | 17.2x |
| Fair Price | (1.94) - (2.04) | (2.24) |
| Upside | -148.1% - -150.4% | -155.4% |
| Date | EV/EBITDA |
| 2025-07-07 | -39.80 |
| 2025-07-03 | -40.77 |
| 2025-07-02 | -40.77 |
| 2025-07-01 | -40.68 |
| 2025-06-30 | -38.23 |
| 2025-06-27 | -38.58 |
| 2025-06-26 | -38.01 |
| 2025-06-25 | -38.23 |
| 2025-06-24 | -38.01 |
| 2025-06-23 | -38.01 |
| 2025-06-20 | -36.73 |
| 2025-06-18 | -37.17 |
| 2025-06-17 | -38.58 |
| 2025-06-16 | -39.19 |
| 2025-06-13 | -38.44 |
| 2025-06-12 | -40.07 |
| 2025-06-11 | -39.89 |
| 2025-06-10 | -41.47 |
| 2025-06-09 | -41.65 |
| 2025-06-06 | -41.12 |
| 2025-06-05 | -38.84 |
| 2025-06-04 | -39.80 |
| 2025-06-03 | -40.59 |
| 2025-06-02 | -38.40 |
| 2025-05-30 | -38.49 |
| 2025-05-29 | -37.96 |
| 2025-05-28 | -37.44 |
| 2025-05-27 | -38.31 |
| 2025-05-23 | -37.17 |
| 2025-05-22 | -37.22 |
| 2025-05-21 | -37.96 |
| 2025-05-20 | -39.72 |
| 2025-05-19 | -39.37 |
| 2025-05-16 | -40.77 |
| 2025-05-15 | -41.21 |
| 2025-05-14 | -41.82 |
| 2025-05-13 | -42.79 |
| 2025-05-12 | -44.80 |
| 2025-05-09 | -41.38 |
| 2025-05-08 | -41.82 |
| 2025-05-07 | -39.98 |
| 2025-05-06 | -40.86 |
| 2025-05-05 | -40.86 |
| 2025-05-02 | -41.91 |
| 2025-05-01 | -40.16 |
| 2025-04-30 | -39.80 |
| 2025-04-29 | -40.86 |
| 2025-04-28 | -40.77 |
| 2025-04-25 | -41.12 |
| 2025-04-24 | -40.07 |